Total Liabilities Summary of OBI Pharma, Inc.

OBI Pharma, Inc.'s latest annual total liabilities in 2023 was 650.44 Million TWD , up 30.73% from previous year.
OBI Pharma, Inc.'s latest quarterly total liabilities in 2024 Q1 was 630.87 Million TWD , down -3.01% from previous quarter.
OBI Pharma, Inc. reported annual total liabilities of 497.56 Million TWD in 2022, down -19.22% from previous year.
OBI Pharma, Inc. reported annual total liabilities of 615.94 Million TWD in 2021, up 22.68% from previous year.
OBI Pharma, Inc. reported quarterly total liabilities of 569.21 Million TWD for 2024 Q2, down -9.77% from previous quarter.
OBI Pharma, Inc. reported quarterly total liabilities of 409.11 Million TWD for 2023 Q1, down -17.78% from previous quarter.

Annual Total Liabilities Chart of OBI Pharma, Inc. (2023 - 2011)

Historical Annual Total Liabilities of OBI Pharma, Inc. (2023 - 2011)

Year	Total Liabilities	Total Liabilities Growth
2023	650.44 Million TWD	30.73%
2022	497.56 Million TWD	-19.22%
2021	615.94 Million TWD	22.68%
2020	502.09 Million TWD	9.35%
2019	459.14 Million TWD	94.53%
2018	236.02 Million TWD	82.04%
2017	129.65 Million TWD	-22.51%
2016	167.31 Million TWD	31.74%
2015	127 Million TWD	187.09%
2014	44.23 Million TWD	6.71%
2013	41.45 Million TWD	-6.63%
2012	44.4 Million TWD	211.09%
2011	14.27 Million TWD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	630.87 Million TWD	-3.01%
2024 Q2	569.21 Million TWD	-9.77%
2023 Q1	409.11 Million TWD	-17.78%
2023 FY	650.44 Million TWD	30.73%
2023 Q2	330.19 Million TWD	-19.29%
2023 Q3	633.71 Million TWD	91.92%
2023 Q4	650.44 Million TWD	2.64%
2022 FY	497.56 Million TWD	-19.22%
2022 Q4	497.56 Million TWD	7.55%
2022 Q3	462.63 Million TWD	0.93%
2022 Q2	458.36 Million TWD	-12.05%
2022 Q1	521.16 Million TWD	-15.39%
2021 Q2	389.87 Million TWD	-0.53%
2021 Q1	391.95 Million TWD	-21.94%
2021 Q4	615.94 Million TWD	45.99%
2021 Q3	421.9 Million TWD	8.21%
2021 FY	615.94 Million TWD	22.68%
2020 Q1	368.58 Million TWD	-19.72%
2020 Q2	361.85 Million TWD	-1.83%
2020 Q3	346.49 Million TWD	-4.24%
2020 Q4	502.09 Million TWD	44.91%
2020 FY	502.09 Million TWD	9.35%
2019 Q2	293.97 Million TWD	2.87%
2019 FY	459.14 Million TWD	94.53%
2019 Q4	459.14 Million TWD	69.2%
2019 Q3	271.35 Million TWD	-7.69%
2019 Q1	285.77 Million TWD	21.08%
2018 FY	236.02 Million TWD	82.04%
2018 Q1	209.18 Million TWD	61.34%
2018 Q4	236.02 Million TWD	37.98%
2018 Q3	171.05 Million TWD	-17.35%
2018 Q2	206.97 Million TWD	-1.06%
2017 FY	129.65 Million TWD	-22.51%
2017 Q4	129.65 Million TWD	36.32%
2017 Q3	95.11 Million TWD	-1.27%
2017 Q2	96.33 Million TWD	-10.63%
2017 Q1	107.79 Million TWD	-35.58%
2016 Q2	35.95 Million TWD	-75.97%
2016 Q4	167.31 Million TWD	505.41%
2016 Q3	27.63 Million TWD	-23.13%
2016 FY	167.31 Million TWD	31.74%
2016 Q1	149.61 Million TWD	17.8%
2015 Q3	41 Million TWD	-16.87%
2015 Q4	127 Million TWD	209.7%
2015 Q2	49.33 Million TWD	-11.97%
2015 Q1	56.03 Million TWD	26.67%
2015 FY	127 Million TWD	187.09%
2014 Q1	- TWD	-100.0%
2014 FY	44.23 Million TWD	6.71%
2014 Q4	44.23 Million TWD	-0.49%
2014 Q3	44.45 Million TWD	-32.77%
2014 Q2	66.12 Million TWD	0.0%
2013 Q2	71.6 Million TWD	0.0%
2013 FY	41.45 Million TWD	-6.63%
2013 Q1	- TWD	-100.0%
2013 Q4	41.45 Million TWD	0.0%
2012 Q3	44.4 Million TWD	0.0%
2012 Q4	44.4 Million TWD	0.0%
2012 FY	44.4 Million TWD	211.09%
2011 FY	14.27 Million TWD	0.0%

Peer Total Liabilities Comparison of OBI Pharma, Inc.

Name	Total Liabilities	Total Liabilities Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	583.48 Million TWD	-11.477%
Level Biotechnology Inc.	273.2 Million TWD	-138.084%
Sagittarius Life Science Corp	137.82 Million TWD	-371.941%
NeoCore Technology Co., Ltd.	197.47 Million TWD	-229.389%
TaiMed Biologics Inc.	1.32 Billion TWD	51.014%
GlycoNex Incorporation	276.39 Million TWD	-135.329%
VBI	21.25 Million TWD	-2960.788%
GeneReach Biotechnology Corp.	313.7 Million TWD	-107.343%
Taiwan Advance Bio-Pharmaceutical Inc.	514.65 Million TWD	-26.386%
Visgeneer Inc.	185.6 Million TWD	-250.447%
Mycenax Biotech Inc.	1.32 Billion TWD	50.843%
Sunmax Biotechnology Co., Ltd.	732.98 Million TWD	11.261%
G&E Herbal Biotechnology Co., Ltd.	119.86 Million TWD	-442.673%
Medigen Vaccine Biologics Corporation	2.24 Billion TWD	71.041%
TaiwanJ Pharmaceuticals Co., Ltd.	6.61 Million TWD	-9728.468%
Enimmune corporation	173.46 Million TWD	-274.978%
TaiRx, Inc.	60.62 Million TWD	-972.904%
CHO Pharma, Inc.	110.83 Million TWD	-486.877%
EirGenix Inc.	1.14 Billion TWD	43.197%
BioLASCO Taiwan Co., Ltd.	111.98 Million TWD	-480.856%
Sunny Pharmtech Inc.	512.43 Million TWD	-26.932%
Lin BioScience, Inc.	167.73 Million TWD	-287.795%
BioGend Therapeutics Co., Ltd.	93.71 Million TWD	-594.078%
Feng Chi Biotech Corp.	63.03 Million TWD	-931.9%
Bio Preventive Medicine Corp.	124.72 Million TWD	-421.489%
Lukas Biomedical Inc.	161.05 Million TWD	-303.857%
RBC Bioscience Corporation	513.08 Million TWD	-26.773%
BiOptic Inc.	170.56 Million TWD	-281.354%
BRIM Biotechnology, Inc.	42.15 Million TWD	-1442.882%
Shine-On BioMedical Co.,Ltd.	23.25 Million TWD	-2697.024%
Great Novel Therapeutics Biotech & Medicals	26.81 Million TWD	-2325.868%
Syngen Biotech Co.,Ltd.	974.63 Million TWD	33.262%
Anti-Microbial Savior BioteQ Co., Ltd	6.99 Million TWD	-9200.086%
SynCore Biotechnology Co.,Ltd	21.22 Million TWD	-2964.393%
Genomics BioSci & Tech. Co.,Ltd.	368.33 Million TWD	-76.593%
Neith Corporation	17.43 Million TWD	-3631.131%
Advagene Biopharma Co., Ltd.	7.97 Million TWD	-8059.157%
NaviFUS Corp.	53.4 Million TWD	-1118.045%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	481.48 Million TWD	-35.091%
Sinew Pharma Inc.	39.71 Million TWD	-1537.83%
Andros Pharmaceuticals Co.,Ltd	58.03 Million TWD	-1020.708%
Greenyn Biotechnology Co., Ltd	364.47 Million TWD	-78.461%
Lumosa Therapeutics Co., Ltd.	227.69 Million TWD	-185.668%
AP Biosciences Inc	106.65 Million TWD	-509.89%
Medigen Biotechnology Corp.	3.53 Billion TWD	81.574%
3D Global Biotech Inc.	30.68 Million TWD	-2020.035%
Pharmosa Biopharm Inc.	195.99 Million TWD	-231.878%
Intech Biopharm Corporation	1.54 Billion TWD	57.851%
Oneness Biotech Co., Ltd.	866.42 Million TWD	24.928%
Eusol Biotech Co.,Ltd.	9.27 Million TWD	-6912.16%
TWi Biotechnology, Inc.	55.81 Million TWD	-1065.406%
Ever Supreme Bio Technology Co., Ltd	232.95 Million TWD	-179.211%
TCI GENE Inc.	155.54 Million TWD	-318.165%
MegaPro Biomedical Co., Ltd	25.5 Million TWD	-2449.976%
Senhwa Biosciences, Inc.	46.17 Million TWD	-1308.658%
Taiwan Bio Therapeutics Co., Ltd	328.47 Million TWD	-98.024%
NatureWise Biotech & Medicals Corporation	64.88 Million TWD	-902.432%
PharmaEngine, Inc.	91 Million TWD	-614.731%
Savior Lifetec Corporation	457.95 Million TWD	-42.033%
TaiGen Biopharmaceuticals Holdings Limited	110.94 Million TWD	-486.306%
Meribank Biotech Co., Ltd	390.81 Million TWD	-66.435%
Acepodia, Inc.	384.47 Million TWD	-69.18%
Caliway Biopharmaceuticals Co., Ltd.	85.55 Million TWD	-660.287%

Global Stocks Search

OBI Pharma, Inc. (4174.TWO)

Total Liabilities Summary of OBI Pharma, Inc.

Annual Total Liabilities Chart of OBI Pharma, Inc. (2023 - 2011)

Historical Annual Total Liabilities of OBI Pharma, Inc. (2023 - 2011)

Peer Total Liabilities Comparison of OBI Pharma, Inc.